PDB Short entry for 3Q5H HEADER HYDROLASE/HYDROLASE INHIBITOR 28-DEC-10 3Q5H TITLE CLINICALLY USEFUL ALKYL AMINE RENIN INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: RENIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 67-406; COMPND 5 SYNONYM: ANGIOTENSINOGENASE; COMPND 6 EC: 3.4.23.15; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: REN, RENIN; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK 293; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PCDNA3.1 KEYWDS ASPARTATE PROTEASE, HYPERTENSION, RENIN EXPRESSION, RENIN INHIBITOR, KEYWDS 2 ASPARTYL PROTEASE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISEASE KEYWDS 3 MUTATION, GLYCOPROTEIN, MEMBRANE, PROTEASE, SECRETED, HYDROLASE- KEYWDS 4 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.WU,B.M.MCKEEVER REVDAT 5 13-SEP-23 3Q5H 1 HETSYN REVDAT 4 29-JUL-20 3Q5H 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 17-JUL-19 3Q5H 1 REMARK LINK REVDAT 2 24-SEP-14 3Q5H 1 JRNL REVDAT 1 30-NOV-11 3Q5H 0 JRNL AUTH L.JIA,R.D.SIMPSON,J.YUAN,Z.XU,W.ZHAO,S.CACATIAN,C.M.TICE, JRNL AUTH 2 J.GUO,A.ISHCHENKO,S.B.SINGH,Z.WU,B.M.MCKEEVER,Y.BUKHTIYAROV, JRNL AUTH 3 J.A.JOHNSON,C.P.DOE,R.K.HARRISON,G.M.MCGEEHAN,L.W.DILLARD, JRNL AUTH 4 J.J.BALDWIN,D.A.CLAREMON JRNL TITL DISCOVERY OF VTP-27999, AN ALKYL AMINE RENIN INHIBITOR WITH JRNL TITL 2 POTENTIAL FOR CLINICAL UTILITY. JRNL REF ACS MED CHEM LETT V. 2 747 2011 JRNL REFN ISSN 1948-5875 JRNL PMID 24900262 JRNL DOI 10.1021/ML200137X REMARK 2 REMARK 2 RESOLUTION. 2.16 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.16 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 39698 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2099 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.16 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.22 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2179 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 72.13 REMARK 3 BIN R VALUE (WORKING SET) : 0.3560 REMARK 3 BIN FREE R VALUE SET COUNT : 106 REMARK 3 BIN FREE R VALUE : 0.4700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5204 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 106 REMARK 3 SOLVENT ATOMS : 168 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03000 REMARK 3 B22 (A**2) : 0.01000 REMARK 3 B33 (A**2) : 0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.279 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.223 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.188 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.626 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5469 ; 0.020 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7419 ; 1.953 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 669 ; 7.966 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 224 ;37.049 ;24.196 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 864 ;18.887 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;18.433 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 839 ; 0.129 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4079 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3329 ; 1.099 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5376 ; 2.019 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2140 ; 3.002 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2043 ; 4.780 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 3 U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 3Q5H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-FEB-11. REMARK 100 THE DEPOSITION ID IS D_1000063218. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-AUG-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.0-8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X8C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.100 REMARK 200 MONOCHROMATOR : SI (111) DOUBLE-CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41821 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.160 REMARK 200 RESOLUTION RANGE LOW (A) : 48.930 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.3100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 3GW5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS-HCL, 0.2 M AMMONIUM REMARK 280 SULFATE, 18-26% PEG3550, 5 MG/ML RENIN, 1 MM INHIBITOR, PH 7.0- REMARK 280 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.32500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.50300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.92500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.50300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.32500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.92500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A -5 REMARK 465 THR A -4 REMARK 465 LEU A -3 REMARK 465 LEU B -5 REMARK 465 THR B -4 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O7 NAG C 1 O HOH A 1017 1.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 157 NE - CZ - NH1 ANGL. DEV. = -3.1 DEGREES REMARK 500 LEU A 205 CA - CB - CG ANGL. DEV. = 14.0 DEGREES REMARK 500 ARG A 307 NE - CZ - NH1 ANGL. DEV. = -3.5 DEGREES REMARK 500 LEU B 161 CA - C - N ANGL. DEV. = -18.9 DEGREES REMARK 500 ARG B 315 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 ARG B 316 NE - CZ - NH1 ANGL. DEV. = -4.3 DEGREES REMARK 500 ARG B 316 NE - CZ - NH2 ANGL. DEV. = 4.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A -1 19.57 -140.09 REMARK 500 ASN A 67 -52.51 -141.60 REMARK 500 SER A 160D 111.05 90.56 REMARK 500 PRO A 172 0.55 -69.04 REMARK 500 ARG A 240 -165.81 -112.50 REMARK 500 ALA A 285 46.84 -87.71 REMARK 500 ARG B 47 -33.79 -37.68 REMARK 500 LEU B 47A 25.35 -64.23 REMARK 500 ASP B 60 9.43 -151.70 REMARK 500 ASN B 67 -53.04 -138.68 REMARK 500 ARG B 132 15.41 47.98 REMARK 500 SER B 160B 5.51 -53.77 REMARK 500 GLN B 160C -96.41 -150.29 REMARK 500 SER B 160D 109.14 4.62 REMARK 500 ALA B 285 45.55 -92.39 REMARK 500 ASN B 318 62.66 36.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY B 144 VAL B 145 -142.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 LEU B 161 23.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3GW5 RELATED DB: PDB REMARK 900 RENIN COMPLEXED WITH A SIMILAR ALKYL AMINE INHIBITOR REMARK 900 RELATED ID: 3KM4 RELATED DB: PDB REMARK 900 RENIN COMPLEXED WITH A SIMILAR ALKYL AMINE INHIBITOR REMARK 900 RELATED ID: 3Q3T RELATED DB: PDB REMARK 900 RENIN COMPLEXED WITH A SIMILAR ALKYL AMINE INHIBITOR REMARK 900 RELATED ID: 3Q4B RELATED DB: PDB REMARK 900 RENIN COMPLEXED WITH A SIMILAR ALKYL AMINE INHIBITOR DBREF 3Q5H A -5 326 UNP P00797 RENI_HUMAN 67 406 DBREF 3Q5H B -5 326 UNP P00797 RENI_HUMAN 67 406 SEQRES 1 A 340 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 A 340 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 A 340 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 A 340 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 A 340 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 A 340 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 A 340 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 A 340 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 A 340 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 A 340 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 A 340 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 A 340 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 A 340 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 A 340 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 A 340 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 A 340 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 A 340 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 A 340 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 A 340 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 A 340 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 A 340 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 A 340 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 A 340 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 A 340 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 A 340 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 A 340 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 A 340 ALA ARG SEQRES 1 B 340 LEU THR LEU GLY ASN THR THR SER SER VAL ILE LEU THR SEQRES 2 B 340 ASN TYR MET ASP THR GLN TYR TYR GLY GLU ILE GLY ILE SEQRES 3 B 340 GLY THR PRO PRO GLN THR PHE LYS VAL VAL PHE ASP THR SEQRES 4 B 340 GLY SER SER ASN VAL TRP VAL PRO SER SER LYS CYS SER SEQRES 5 B 340 ARG LEU TYR THR ALA CYS VAL TYR HIS LYS LEU PHE ASP SEQRES 6 B 340 ALA SER ASP SER SER SER TYR LYS HIS ASN GLY THR GLU SEQRES 7 B 340 LEU THR LEU ARG TYR SER THR GLY THR VAL SER GLY PHE SEQRES 8 B 340 LEU SER GLN ASP ILE ILE THR VAL GLY GLY ILE THR VAL SEQRES 9 B 340 THR GLN MET PHE GLY GLU VAL THR GLU MET PRO ALA LEU SEQRES 10 B 340 PRO PHE MET LEU ALA GLU PHE ASP GLY VAL VAL GLY MET SEQRES 11 B 340 GLY PHE ILE GLU GLN ALA ILE GLY ARG VAL THR PRO ILE SEQRES 12 B 340 PHE ASP ASN ILE ILE SER GLN GLY VAL LEU LYS GLU ASP SEQRES 13 B 340 VAL PHE SER PHE TYR TYR ASN ARG ASP SER GLU ASN SER SEQRES 14 B 340 GLN SER LEU GLY GLY GLN ILE VAL LEU GLY GLY SER ASP SEQRES 15 B 340 PRO GLN HIS TYR GLU GLY ASN PHE HIS TYR ILE ASN LEU SEQRES 16 B 340 ILE LYS THR GLY VAL TRP GLN ILE GLN MET LYS GLY VAL SEQRES 17 B 340 SER VAL GLY SER SER THR LEU LEU CYS GLU ASP GLY CYS SEQRES 18 B 340 LEU ALA LEU VAL ASP THR GLY ALA SER TYR ILE SER GLY SEQRES 19 B 340 SER THR SER SER ILE GLU LYS LEU MET GLU ALA LEU GLY SEQRES 20 B 340 ALA LYS LYS ARG LEU PHE ASP TYR VAL VAL LYS CYS ASN SEQRES 21 B 340 GLU GLY PRO THR LEU PRO ASP ILE SER PHE HIS LEU GLY SEQRES 22 B 340 GLY LYS GLU TYR THR LEU THR SER ALA ASP TYR VAL PHE SEQRES 23 B 340 GLN GLU SER TYR SER SER LYS LYS LEU CYS THR LEU ALA SEQRES 24 B 340 ILE HIS ALA MET ASP ILE PRO PRO PRO THR GLY PRO THR SEQRES 25 B 340 TRP ALA LEU GLY ALA THR PHE ILE ARG LYS PHE TYR THR SEQRES 26 B 340 GLU PHE ASP ARG ARG ASN ASN ARG ILE GLY PHE ALA LEU SEQRES 27 B 340 ALA ARG MODRES 3Q5H ASN A 67 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET CL A 500 1 HET RX6 A 335 36 HET CL A 336 1 HET CL A 337 1 HET CL A 338 1 HET CL B 500 1 HET RX6 B 335 36 HET CL B 336 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CL CHLORIDE ION HETNAM RX6 METHYL (2-{(R)-(3-CHLOROPHENYL)[(3R)-1-({(2S)-1- HETNAM 2 RX6 (METHYLAMINO)-3-[(3R)-TETRAHYDRO-2H-PYRAN-3-YL]PROPAN- HETNAM 3 RX6 2-YL}CARBAMOYL)PIPERIDIN-3-YL]METHOXY}ETHYL)CARBAMATE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 4 CL 6(CL 1-) FORMUL 5 RX6 2(C26 H41 CL N4 O5) FORMUL 12 HOH *168(H2 O) HELIX 1 1 TYR A 47B TYR A 52 1 6 HELIX 2 2 ASP A 57 SER A 61 5 5 HELIX 3 3 PRO A 108 MET A 113 1 6 HELIX 4 4 PHE A 125 VAL A 133 5 9 HELIX 5 5 PRO A 135 SER A 142 1 8 HELIX 6 6 ASP A 171 TYR A 175 5 5 HELIX 7 7 SER A 224 GLY A 236 1 13 HELIX 8 8 GLU A 251 LEU A 255 5 5 HELIX 9 9 THR A 270 VAL A 275 1 6 HELIX 10 10 GLY A 302 LYS A 308 1 7 HELIX 11 11 TYR B 47B HIS B 53 1 7 HELIX 12 12 ASP B 57 SER B 61 5 5 HELIX 13 13 PRO B 108 MET B 113 1 6 HELIX 14 14 PHE B 125 VAL B 133 5 9 HELIX 15 15 PRO B 135 SER B 142 1 8 HELIX 16 16 SER B 224 LEU B 235 1 12 HELIX 17 17 ASN B 250 LEU B 255 5 6 HELIX 18 18 THR B 270 VAL B 275 1 6 HELIX 19 19 GLY B 302 ARG B 307 1 6 SHEET 1 A 9 LYS A 65 TYR A 75 0 SHEET 2 A 9 GLY A 78 VAL A 91 -1 O GLY A 78 N TYR A 75 SHEET 3 A 9 GLN A 13 ILE A 20 -1 N GLY A 19 O THR A 90 SHEET 4 A 9 SER A 2 TYR A 9 -1 N TYR A 9 O GLN A 13 SHEET 5 A 9 GLY A 163 LEU A 167 -1 O GLY A 163 N LEU A 6 SHEET 6 A 9 VAL A 150 TYR A 155 -1 N TYR A 154 O GLN A 164 SHEET 7 A 9 PHE A 309 ASP A 314 -1 O PHE A 313 N PHE A 151 SHEET 8 A 9 ARG A 319 LEU A 324 -1 O GLY A 321 N GLU A 312 SHEET 9 A 9 HIS A 180 ASN A 183 -1 N ILE A 182 O ILE A 320 SHEET 1 B13 LYS A 65 TYR A 75 0 SHEET 2 B13 GLY A 78 VAL A 91 -1 O GLY A 78 N TYR A 75 SHEET 3 B13 ILE A 94 GLU A 106 -1 O VAL A 96 N ILE A 89 SHEET 4 B13 VAL A 38 PRO A 41 1 N VAL A 40 O VAL A 104 SHEET 5 B13 GLY A 119 GLY A 122 -1 O VAL A 120 N TRP A 39 SHEET 6 B13 GLN A 25 ASP A 32 1 N VAL A 30 O VAL A 121 SHEET 7 B13 GLN A 13 ILE A 20 -1 N ILE A 20 O GLN A 25 SHEET 8 B13 SER A 2 TYR A 9 -1 N TYR A 9 O GLN A 13 SHEET 9 B13 GLY A 163 LEU A 167 -1 O GLY A 163 N LEU A 6 SHEET 10 B13 VAL A 150 TYR A 155 -1 N TYR A 154 O GLN A 164 SHEET 11 B13 PHE A 309 ASP A 314 -1 O PHE A 313 N PHE A 151 SHEET 12 B13 ARG A 319 LEU A 324 -1 O GLY A 321 N GLU A 312 SHEET 13 B13 HIS A 180 ASN A 183 -1 N ILE A 182 O ILE A 320 SHEET 1 C 3 GLN A 191 MET A 194 0 SHEET 2 C 3 CYS A 210 VAL A 214 -1 O CYS A 210 N MET A 194 SHEET 3 C 3 TRP A 299 LEU A 301 1 O LEU A 301 N LEU A 213 SHEET 1 D 3 GLY A 196 VAL A 199 0 SHEET 2 D 3 ILE A 258 LEU A 262 -1 O SER A 259 N SER A 198 SHEET 3 D 3 LYS A 265 LEU A 269 -1 O TYR A 267 N PHE A 260 SHEET 1 E 2 ILE A 221 GLY A 223 0 SHEET 2 E 2 ILE A 286 ALA A 288 1 O HIS A 287 N ILE A 221 SHEET 1 F 3 LYS A 238 LYS A 239 0 SHEET 2 F 3 TYR A 245 LYS A 248 -1 O VAL A 246 N LYS A 238 SHEET 3 F 3 LEU A 281D THR A 283 -1 O CYS A 282 N VAL A 247 SHEET 1 G 9 GLU B 70 ARG B 74 0 SHEET 2 G 9 THR B 79 VAL B 91 -1 O GLY B 82 N LEU B 71 SHEET 3 G 9 GLN B 13 ILE B 20 -1 N GLY B 19 O THR B 90 SHEET 4 G 9 SER B 2 TYR B 9 -1 N TYR B 9 O GLN B 13 SHEET 5 G 9 GLY B 163 LEU B 167 -1 O GLY B 163 N LEU B 6 SHEET 6 G 9 VAL B 150 TYR B 155 -1 N TYR B 154 O GLN B 164 SHEET 7 G 9 PHE B 309 ASP B 314 -1 O PHE B 313 N PHE B 151 SHEET 8 G 9 ARG B 319 ALA B 325 -1 O GLY B 321 N GLU B 312 SHEET 9 G 9 TYR B 175 ASN B 183 -1 N GLU B 176 O LEU B 324 SHEET 1 H13 GLU B 70 ARG B 74 0 SHEET 2 H13 THR B 79 VAL B 91 -1 O GLY B 82 N LEU B 71 SHEET 3 H13 ILE B 94 GLU B 106 -1 O VAL B 96 N ILE B 89 SHEET 4 H13 VAL B 38 PRO B 41 1 N VAL B 40 O VAL B 104 SHEET 5 H13 GLY B 119 GLY B 122 -1 O VAL B 120 N TRP B 39 SHEET 6 H13 GLN B 25 ASP B 32 1 N VAL B 30 O VAL B 121 SHEET 7 H13 GLN B 13 ILE B 20 -1 N ILE B 20 O GLN B 25 SHEET 8 H13 SER B 2 TYR B 9 -1 N TYR B 9 O GLN B 13 SHEET 9 H13 GLY B 163 LEU B 167 -1 O GLY B 163 N LEU B 6 SHEET 10 H13 VAL B 150 TYR B 155 -1 N TYR B 154 O GLN B 164 SHEET 11 H13 PHE B 309 ASP B 314 -1 O PHE B 313 N PHE B 151 SHEET 12 H13 ARG B 319 ALA B 325 -1 O GLY B 321 N GLU B 312 SHEET 13 H13 TYR B 175 ASN B 183 -1 N GLU B 176 O LEU B 324 SHEET 1 I 4 SER B 202 LEU B 205 0 SHEET 2 I 4 GLN B 191 VAL B 199 -1 N VAL B 197 O LEU B 204 SHEET 3 I 4 ILE B 258 LEU B 262 -1 O SER B 259 N SER B 198 SHEET 4 I 4 LYS B 265 LEU B 269 -1 O LEU B 269 N ILE B 258 SHEET 1 J 6 SER B 202 LEU B 205 0 SHEET 2 J 6 GLN B 191 VAL B 199 -1 N VAL B 197 O LEU B 204 SHEET 3 J 6 CYS B 210 VAL B 214 -1 O CYS B 210 N MET B 194 SHEET 4 J 6 TRP B 299 LEU B 301 1 O LEU B 301 N LEU B 213 SHEET 5 J 6 ILE B 221 GLY B 223 -1 N SER B 222 O ALA B 300 SHEET 6 J 6 ILE B 286 ALA B 288 1 O HIS B 287 N ILE B 221 SHEET 1 K 3 LYS B 238 LYS B 239 0 SHEET 2 K 3 TYR B 245 LYS B 248 -1 O VAL B 246 N LYS B 238 SHEET 3 K 3 LEU B 281D THR B 283 -1 O CYS B 282 N VAL B 247 SSBOND 1 CYS A 45 CYS A 50 1555 1555 2.00 SSBOND 2 CYS A 206 CYS A 210 1555 1555 2.04 SSBOND 3 CYS A 249 CYS A 282 1555 1555 2.04 SSBOND 4 CYS B 45 CYS B 50 1555 1555 2.02 SSBOND 5 CYS B 206 CYS B 210 1555 1555 2.08 SSBOND 6 CYS B 249 CYS B 282 1555 1555 2.11 LINK ND2 ASN A 67 C1 NAG C 1 1555 1555 1.49 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 CISPEP 1 THR A 22 PRO A 23 0 -1.62 CISPEP 2 GLY A 92 GLY A 93 0 21.91 CISPEP 3 LEU A 110 PRO A 111 0 2.64 CISPEP 4 PRO A 293 PRO A 294 0 -0.37 CISPEP 5 GLY A 296 PRO A 297 0 0.65 CISPEP 6 THR B 22 PRO B 23 0 -5.11 CISPEP 7 LEU B 110 PRO B 111 0 13.69 CISPEP 8 PRO B 293 PRO B 294 0 1.70 CISPEP 9 GLY B 296 PRO B 297 0 -8.63 CRYST1 54.650 97.850 149.006 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018298 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010220 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006711 0.00000